Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
Condition(s):Venous Thromboses; Stent StenosisLast Updated:May 26, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Venous Thromboses; Stent StenosisLast Updated:May 26, 2022Recruiting
Condition(s):PreeclampsiaLast Updated:February 2, 2022Recruiting
Condition(s):AspirinLast Updated:September 6, 2019Completed
Condition(s):Cardiovascular DiseasesLast Updated:June 24, 2022Terminated
Condition(s):Pre-EclampsiaLast Updated:March 10, 2021Not yet recruiting
Condition(s):Hypertrophic Obstructive CardiomyopathyLast Updated:April 26, 2022Recruiting
Condition(s):Stable Angina Pectoris; Coronary Artery Disease; Ischemic Heart DiseaseLast Updated:May 10, 2022Not yet recruiting
Condition(s):Intracranial Aneurysm; InflammationLast Updated:October 28, 2019Unknown status
Condition(s):Coronary Artery DiseaseLast Updated:April 21, 2016Completed
Condition(s):Uncontrolled AsthmaLast Updated:February 7, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.